Publication | Closed Access

Cerebrospinal fluid ATP as a potential biomarker in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes (MELAS)

Mitochondrial MyopathyMitochondrial FunctionCerebrospinal Fluid AtpMedicineCerebrospinal FluidPhysiologyPotential BiomarkerNeurochemical BiomarkersBrain InjuryNeurologyNeuroscienceCerebral Blood FlowStrokeCerebral Vascular RegulationHealth Sciences